ALPHATAC

Welcome to the Brand page for “ALPHATAC”, which is offered here for Pharmaceutical, medical and veterinary preparations for the treatment of cardiovascular diseases, allergies, immune and inflammatory diseases, metabolic diseases, cancer, diseases of the central nervous system, musculoskeletal diseases, ophthalmological diseases, and infectious diseases in humans and livestock; diagnostics preparations for medical and veterinary purposes and diagnostic materials, diagnostic reagents and media for diagnosing cardiovascular diseases, allergies, immune and inflammatory diseases, metabolic diseases, cancer, diseases of the central nervous systems, musculoskeletal diseases, ophthalmological diseases, and infectious diseases in humans and livestock; pharmaceutical preparations, being bioculture preparations for the treatment of cardiovascular diseases, allergies, immune and inflammatory diseases, metabolic diseases, cancer, diseases of the central nervous system, musculoskeletal diseases, ophthalmological diseases, and infectious diseases in humans and livestock; veterinary diagnostic reagents and diagnostic reagents for medicinal use, preparations and substances for use in drug discovery and structural biology, proteins and protein conjugates in raw material form or as formulated reagents;science and technology services, technical consultancy and research in the fields of drug discovery, structural biology research, and biotechnology research; science and technology services, scientific and laboratory research in the medical, bacteriological, biotechnical, pharmaceutical and diagnostic fields; natural science services, research in the field of structural biology, engineering, and biotechnology; medical and pharmacological research services; clinical research in the fields of cardiovascular diseases, allergies, immune and inflammatory diseases, metabolic diseases, cancer, diseases of the central nervous system, and infectious diseases; clinical research in the fields of medical and biotechnological procedures, radiology, chemotherapy and in vivo imaging; medical laboratories; conducting early evaluations in the field of new pharmaceuticals; consultancy relating to pharmaceutical research and development; drug discovery services; laboratory services relating to the production of proteins and protein conjugates; information technology services for the pharmaceutical and healthcare industries;.

Its status is currently believed to be active. Its class is unavailable. “ALPHATAC” is believed to be currently owned by “VIB vzw”.